GMR Solutions Earnings Call Transcripts
Fiscal Year 2026
-
Q3 revenue rose 5.9% and adjusted EBITDA 4.2%, with strong free cash flow and lower leverage. 2026 revenue guidance was narrowed amid weather-related air softness and inflation, while adjusted EBITDA guidance was maintained.
-
A national EMS provider leverages scale, innovation, and technology to drive margin and EBITDA growth, focusing on core urgent care, expanding Nurse Navigation, and pursuing disciplined M&A and de-leveraging. Legislative efforts and payer negotiations support future reimbursement gains.
-
Q2 2026 saw 3.3% revenue growth to $1.49B, with strong air and emergent ground volumes, but adjusted EBITDA fell 11.8% due to prior year one-time items and higher costs. Guidance for the year is reiterated, with stable leverage and ongoing investments in technology and market expansion.
-
Q1 2026 saw 6.6% revenue growth and 9.7% adjusted EBITDA growth, with strong operational execution and improved leverage post-IPO. Guidance reflects payer mix headwinds, higher fuel costs, and continued focus on core EMS services, with robust cash flow supporting further deleveraging.